VA
Castle Biosciences Awarded VA Supply Contract for Melanoma Test
The company said the contract will provide greater access to its DecisionDx-Melanoma gene expression profile test for veterans and active duty military.
VA Not Covering Alzheimer's Disease Drug
The Wall Street Journal reports the US Department of Veterans Affairs won't cover Biogen's controversial Alzheimer's disease drug.
Personalis Q2 Revenues Rise 11 Percent
Revenues from the Veterans Affairs Million Veteran Program shrank slightly while those from non-VA MVP customers were up 74 percent.
Push for More Women in Million Veteran Program
The Military Times reports the Million Veteran Program is seeking more female participants.
PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study
In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.
Nov 5, 2020
Personalis Q3 Revenues Up 16 Percent
Aug 6, 2020
Personalis Q2 Revenues Up 23 Percent
May 7, 2020
Personalis Q1 Revenues Up 36 Percent
Nov 13, 2019
Personalis Q3 Revenues Up 47 Percent
Jul 11, 2019
Mar 12, 2019
Jul 19, 2018